RBI cut its median projections for gross value added growth for FY18 to 6.7% from 7.3%
NSDL is promoted by IDBI, the NSE, and the Specified Undertaking of the Unit Trust of India
While most pharma firms suffer, investors cheer some with good product pipeline and improving regulatory record
The move follows Sebi staffers lobbying for more internal promotions
Share price surges 11% as firm emerges as lowest bidder for Rs 5,400 cr order to build anti-submarine vessels for Indian Navy
It is necessary to justify premium valuations for the company
The April-Sept period witnessed the opening of 5 mn new equity accounts, taking the overall tally to 45.8 mn
Risk-reward more favourable in large caps than mid- and small-caps
Evaluation of the fund's performance over various market phases shows it has proved its worth with the ability to contain the downside better than peers during all bear phases under analysis
We are pleased to welcome IREDA's debut Green Masala bond: Head of Debt Capital Markets at Singapore Exchange
According to the study, published in the journal Management Science, this could be a significant contributor to fluctuations in the market
All that happened in Wednesday's trade
The stock was up 2% at Rs 2,510 on the BSE in otherwise subdued market ahead of July-September quarter results on Thursday, October 12, 2017.
Avenue Supermarts, Shankara Building Products, CDSL, PSP Projects, Sheela Foam, Apex Frozen and Endurance Technologies have gained more than 100% against their respective issue price.
The stock rallied 8% to Rs 1,575 in intra-day trade, extending its Tuesday's 6% gain on the BSE.
The stock hit a new high of Rs 466, up 13% on BSE in intra-day trade.
The S&P BSE Smallcap index hit a new high of 17,020, surpassed its previous high of 16,982 touched on September 20, 2017 in intra-day trade.
GIC Re is the largest reinsurance company in India in terms of gross premiums accepted in fiscal 2017
Nifty outlook and few trading ideas by Devarsh Vakil & Vinay Rajani - PCG Desk, HDFC securities
Derivative strategy on Sun Pharma by Chandan Taparia of Motilal Oswal